(ATRO) Astronics - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0464331083

Lighting Systems, Power Systems, Test Equipment, Avionics Structures

Dividends

Currently no dividends paid
Risk via 10d forecast
Volatility 56.1%
Value at Risk 5%th 67.0%
Relative Tail Risk -27.44%
Reward TTM
Sharpe Ratio 2.48
Alpha 194.27
CAGR/Max DD 2.36
Character TTM
Hurst Exponent 0.442
Beta 0.987
Beta Downside 0.941
Drawdowns 3y
Max DD 34.89%
Mean DD 13.34%
Median DD 12.80%

Description: ATRO Astronics November 17, 2025

Astronics Corporation (NASDAQ:ATRO) designs and manufactures aerospace, defense, and electronics products through two operating segments: Aerospace, which supplies lighting, safety, power generation, seat-motion, structural, and avionics solutions to OEMs, airlines, and the U.S. Department of Defense; and Test Systems, which builds automated test equipment and training simulators for aerospace, defense, communications, and mass-transit customers.

In FY 2023 the company generated roughly $1.2 billion in revenue, with the Aerospace segment contributing about 65 % of sales and delivering an operating margin near 9 %. Backlog growth has been driven by a resurgence in commercial air travel and sustained U.S. defense spending, while the Test Systems segment benefits from increasing demand for high-mix, low-volume electronic testing as aircraft become more software-centric. A key sector catalyst is the global push toward greener, LED-based cabin lighting, which aligns with airlines’ fuel-efficiency and passenger-experience initiatives.

For a deeper quantitative assessment, you may find ValueRay’s analyst tools useful for modeling ATRO’s valuation under different demand scenarios.

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (-3.09m TTM) > 0 and > 6% of Revenue (6% = 49.8m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA 8.19pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 33.91% (prev 35.05%; Δ -1.14pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.11 (>3.0%) and CFO 74.3m > Net Income -3.09m (YES >=105%, WARN >=100%)
Net Debt (365.9m) to EBITDA (39.6m) ratio: 9.25 <= 3.0 (WARN <= 3.5)
Current Ratio 2.87 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (35.4m) change vs 12m ago 1.18% (target <= -2.0% for YES)
Gross Margin 27.48% (prev 23.75%; Δ 3.73pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 124.5% (prev 120.0%; Δ 4.51pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.32 (EBITDA TTM 39.6m / Interest Expense TTM 13.3m) >= 6 (WARN >= 3)

Altman Z'' 4.00

(A) 0.41 = (Total Current Assets 432.6m - Total Current Liabilities 151.0m) / Total Assets 682.2m
(B) 0.28 = Retained Earnings (Balance) 192.2m / Total Assets 682.2m
(C) 0.03 = EBIT TTM 17.6m / Avg Total Assets 666.9m
(D) 0.19 = Book Value of Equity 108.9m / Total Liabilities 573.3m
Total Rating: 4.00 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 50.84

1. Piotroski 5.0pt
2. FCF Yield 2.22%
3. FCF Margin 6.17%
4. Debt/Equity 3.48
5. Debt/Ebitda 9.25
6. ROIC - WACC (= -4.52)%
7. RoE -1.37%
8. Rev. Trend 56.87%
9. EPS Trend 75.17%

What is the price of ATRO shares?

As of December 01, 2025, the stock is trading at USD 54.57 with a total of 196,999 shares traded.
Over the past week, the price has changed by +8.12%, over one month by +10.96%, over three months by +49.47% and over the past year by +229.33%.

Is ATRO a buy, sell or hold?

Astronics has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold ATRO.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the ATRO price?

Issuer Target Up/Down from current
Wallstreet Target Price 62.8 15%
Analysts Target Price 62.8 15%
ValueRay Target Price 84.7 55.3%

ATRO Fundamental Data Overview November 29, 2025

Market Cap USD = 1.95b (1.95b USD * 1.0 USD.USD)
P/E Forward = 46.9484
P/S = 2.3434
P/B = 17.8754
P/EG = 1.4638
Beta = 1.134
Revenue TTM = 830.6m USD
EBIT TTM = 17.6m USD
EBITDA TTM = 39.6m USD
Long Term Debt = 334.0m USD (from longTermDebt, last quarter)
Short Term Debt = 6.02m USD (from shortTermDebt, last quarter)
Debt = 379.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 365.9m USD (from netDebt column, last quarter)
Enterprise Value = 2.31b USD (1.95b + Debt 379.4m - CCE 13.5m)
Interest Coverage Ratio = 1.32 (Ebit TTM 17.6m / Interest Expense TTM 13.3m)
FCF Yield = 2.22% (FCF TTM 51.3m / Enterprise Value 2.31b)
FCF Margin = 6.17% (FCF TTM 51.3m / Revenue TTM 830.6m)
Net Margin = -0.37% (Net Income TTM -3.09m / Revenue TTM 830.6m)
Gross Margin = 27.48% ((Revenue TTM 830.6m - Cost of Revenue TTM 602.4m) / Revenue TTM)
Gross Margin QoQ = 30.51% (prev 25.81%)
Tobins Q-Ratio = 3.39 (Enterprise Value 2.31b / Total Assets 682.2m)
Interest Expense / Debt = 0.77% (Interest Expense 2.92m / Debt 379.4m)
Taxrate = 9.95% (-1.23m / -12.3m)
NOPAT = 15.8m (EBIT 17.6m * (1 - 9.95%))
Current Ratio = 2.87 (Total Current Assets 432.6m / Total Current Liabilities 151.0m)
Debt / Equity = 3.48 (Debt 379.4m / totalStockholderEquity, last quarter 108.9m)
Debt / EBITDA = 9.25 (Net Debt 365.9m / EBITDA 39.6m)
Debt / FCF = 7.13 (Net Debt 365.9m / FCF TTM 51.3m)
Total Stockholder Equity = 225.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.45% (Net Income -3.09m / Total Assets 682.2m)
RoE = -1.37% (Net Income TTM -3.09m / Total Stockholder Equity 225.8m)
RoCE = 3.14% (EBIT 17.6m / Capital Employed (Equity 225.8m + L.T.Debt 334.0m))
RoIC = 3.66% (NOPAT 15.8m / Invested Capital 431.4m)
WACC = 8.19% (E(1.95b)/V(2.33b) * Re(9.65%) + D(379.4m)/V(2.33b) * Rd(0.77%) * (1-Tc(0.10)))
Discount Rate = 9.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.78%
[DCF Debug] Terminal Value 63.55% ; FCFE base≈51.3m ; Y1≈33.7m ; Y5≈15.4m
Fair Price DCF = 7.49 (DCF Value 236.7m / Shares Outstanding 31.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 75.17 | EPS CAGR: 37.33% | SUE: 0.74 | # QB: 0
Revenue Correlation: 56.87 | Revenue CAGR: 17.35% | SUE: -0.01 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.56 | Chg30d=+0.094 | Revisions Net=+2 | Analysts=4
EPS current Year (2025-12-31): EPS=1.82 | Chg30d=+0.134 | Revisions Net=+3 | Growth EPS=+67.0% | Growth Revenue=+7.1%
EPS next Year (2026-12-31): EPS=2.40 | Chg30d=+0.332 | Revisions Net=+3 | Growth EPS=+32.3% | Growth Revenue=+11.5%

Additional Sources for ATRO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle